Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23744026)

1.

Ventilator-associated pneumonia caused by OXA-48-producing Escherichia coli complicated by ciprofloxacin-associated rhabdomyolysis.

Grisold AJ, Hoenigl M, Ovcina I, Valentin T, Fruhwald S.

J Infect Chemother. 2013 Dec;19(6):1214-7. doi: 10.1007/s10156-013-0628-3. Epub 2013 Jun 7.

PMID:
23744026
2.

Cytosorb™ in a patient with Legionella pneumonia-associated rhabdomyolysis: a case report.

Wiegele M, Krenn CG.

ASAIO J. 2015 May-Jun;61(3):e14-6. doi: 10.1097/MAT.0000000000000197. No abstract available.

PMID:
25635933
3.

[Pyomiositis caused by Escherichia coli in a patient on chronic glucocorticoid treatment.]

Vazquez-Ledo L, Alende-Castro V, Macía-Rodriguez C, Novo-Veleiro I.

Enferm Infecc Microbiol Clin. 2014 Dec 1. pii: S0213-005X(14)00336-X. doi: 10.1016/j.eimc.2014.09.015. [Epub ahead of print] Spanish. No abstract available.

PMID:
25475655
4.

Emergence of OXA-48-producing Escherichia coli clone ST38 in fowl.

Al Bayssari C, Olaitan AO, Dabboussi F, Hamze M, Rolain JM.

Antimicrob Agents Chemother. 2015 Jan;59(1):745-6. doi: 10.1128/AAC.03552-14. Epub 2014 Oct 27. No abstract available.

5.

Ciprofloxacin-induced psychosis.

Ranjan A, Praharaj SK.

J Neuropsychiatry Clin Neurosci. 2014 Winter;26(1):E36-7. doi: 10.1176/appi.neuropsych.13020033. No abstract available.

PMID:
24515705
6.

Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.

Ha YE, Kang CI, Cha MK, Park SY, Wi YM, Chung DR, Peck KR, Lee NY, Song JH.

Int J Antimicrob Agents. 2013 Nov;42(5):403-9. doi: 10.1016/j.ijantimicag.2013.07.018. Epub 2013 Sep 7.

PMID:
24071027
7.

Tigecycline treatment of infection caused by KPC-producing Escherichia coli in a pediatric patient.

Du X, Fu Y, Yu Y.

Ann Clin Microbiol Antimicrob. 2013 Aug 13;12:19. doi: 10.1186/1476-0711-12-19.

8.

Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.

Stolle I, Prenger-Berninghoff E, Stamm I, Scheufen S, Hassdenteufel E, Guenther S, Bethe A, Pfeifer Y, Ewers C.

J Antimicrob Chemother. 2013 Dec;68(12):2802-8. doi: 10.1093/jac/dkt259. Epub 2013 Jul 5.

9.

Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large U.S. Medical Center.

Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, Gudur UM, Pulluru H, Bathina P, Sundaragiri PR, Sarkar M, Kakarlapudi H, Ramasamy B, Nanjireddy P, Mohin S, Dasagi M, Datla S, Kuchipudi V, Reddy S, Shahani S, Upputuri V, Marrey S, Gannamani V, Madhanagopal N, Annangi S, Sudha B, Muppavarapu KS, Moshos JA, Lephart PR, Pogue JM, Bush K, Kaye KS.

Antimicrob Agents Chemother. 2013 Aug;57(8):4010-8. doi: 10.1128/AAC.02516-12. Epub 2013 Jun 10.

10.

OXA-48-like carbapenemase-producing Enterobacteriaceae in Ottawa, Canada.

Ellis C, Chung C, Tijet N, Patel SN, Desjardins M, Melano RG, Toye B.

Diagn Microbiol Infect Dis. 2013 Jul;76(3):399-400. doi: 10.1016/j.diagmicrobio.2013.04.017. Epub 2013 May 25. No abstract available.

PMID:
23711532
11.

Nosocomial ventilator-associated pneumonia in Cuban intensive care units: bacterial species and antibiotic resistance.

Medell M, Hart M, Duquesne A, Espinosa F, Valdés R.

MEDICC Rev. 2013 Apr;15(2):26-9.

12.

Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.

Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout JD.

Antimicrob Agents Chemother. 2013 Jul;57(7):3085-91. doi: 10.1128/AAC.00297-13. Epub 2013 Apr 22.

13.

Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.

Denisuik AJ, Lagacé-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance.

J Antimicrob Chemother. 2013 May;68 Suppl 1:i57-65. doi: 10.1093/jac/dkt027.

14.

Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.

Kang CI, Wi YM, Ko KS, Chung DR, Peck KR, Lee NY, Song JH.

Scand J Infect Dis. 2013 Jul;45(7):519-25. doi: 10.3109/00365548.2013.775479. Epub 2013 Mar 19.

PMID:
23509913
15.

Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu.

Domínguez-Herrera J, Velasco C, Docobo-Pérez F, Rodríguez-Martínez JM, López-Rojas R, Briales A, Pichardo C, Díaz-de-Alba P, Rodríguez-Baño J, Pascual A, Pachón J.

J Antimicrob Chemother. 2013 Jul;68(7):1609-15. doi: 10.1093/jac/dkt063. Epub 2013 Mar 14.

16.

Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli.

Beyrouthy R, Robin F, Cougnoux A, Dalmasso G, Darfeuille-Michaud A, Mallat H, Dabboussi F, Hamzé M, Bonnet R.

J Antimicrob Chemother. 2013 Jul;68(7):1558-61. doi: 10.1093/jac/dkt051. Epub 2013 Feb 26.

17.

[Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].

González Mesa L, Ramos Morí A, Nadal Becerra L, Morffi Figueroa J, Hernández Robledo E, Alvarez AB, Marchena Bequer JJ, González Alemán M, Villain Plous C.

Rev Cubana Med Trop. 2007 Jan-Apr;59(1):52-8. Spanish.

PMID:
23427419
18.

Genetic characterisation of extended-spectrum β-lactamases in Escherichia coli isolated from retail chicken products including CTX-M-9 containing isolates: a food safety risk factor.

Silva N, Costa L, Gonçalves A, Sousa M, Radhouani H, Brito F, Igrejas G, Poeta P.

Br Poult Sci. 2012;53(6):747-55. doi: 10.1080/00071668.2012.740554.

PMID:
23398418
19.

Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.

Mavroidi A, Miriagou V, Liakopoulos A, Tzelepi Ε, Stefos A, Dalekos GN, Petinaki E.

BMC Infect Dis. 2012 Dec 23;12:371. doi: 10.1186/1471-2334-12-371.

20.

Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge.

Navarro-San Francisco C, Mora-Rillo M, Romero-Gómez MP, Moreno-Ramos F, Rico-Nieto A, Ruiz-Carrascoso G, Gómez-Gil R, Arribas-López JR, Mingorance J, Paño-Pardo JR.

Clin Microbiol Infect. 2013 Feb;19(2):E72-9. doi: 10.1111/1469-0691.12091. Epub 2012 Dec 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk